<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Life Sciences</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/5901F62B-F850-4224-AE87-91CABEDAB91F"><gtr:id>5901F62B-F850-4224-AE87-91CABEDAB91F</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:otherNames>Paul</gtr:otherNames><gtr:surname>Harbottle</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DB121CC9-E948-4D1C-96D7-5B2FEB2D6B39"><gtr:id>DB121CC9-E948-4D1C-96D7-5B2FEB2D6B39</gtr:id><gtr:firstName>Charles</gtr:firstName><gtr:surname>Coutelle</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9696B28C-46C5-4424-832D-664653F74941"><gtr:id>9696B28C-46C5-4424-832D-664653F74941</gtr:id><gtr:firstName>Oleg</gtr:firstName><gtr:surname>Tolmachov</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0300705"><gtr:id>86C1894E-1D0F-4602-A4D1-9DE91A758D74</gtr:id><gtr:title>Development of a nuclear targeted, stably maintained non-viral minicircle gene therapy vector</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0300705</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>210068</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>0214BF79-6571-41B1-A731-3A2088915DF9</gtr:id><gtr:title>Nuclear-targeted minicircle to enhance gene transfer with non-viral vectors in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>The journal of gene medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1893f22f51ac65702850b328f0b98bef"><gtr:id>1893f22f51ac65702850b328f0b98bef</gtr:id><gtr:otherNames>Vaysse L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1099-498X</gtr:issn><gtr:outcomeId>43CA150AC4F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C333353-AD12-4903-8F46-D6D4586C9BA5</gtr:id><gtr:title>RecET driven chromosomal gene targeting to generate a RecA deficient Escherichia coli strain for Cre mediated production of minicircle DNA.</gtr:title><gtr:parentPublicationTitle>BMC biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e6b934125a1682dce74076115330a1a"><gtr:id>0e6b934125a1682dce74076115330a1a</gtr:id><gtr:otherNames>Tolmachov O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1472-6750</gtr:issn><gtr:outcomeId>2F27F103A8F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C308885-9E0C-4229-A998-1AD43034F876</gtr:id><gtr:title>Development of a self-assembling nuclear targeting vector system based on the tetracycline repressor protein.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1893f22f51ac65702850b328f0b98bef"><gtr:id>1893f22f51ac65702850b328f0b98bef</gtr:id><gtr:otherNames>Vaysse L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>74B9B6874ED</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>261512F2-C7AD-4550-9772-99269035C72B</gtr:id><gtr:title>Covalent attachment of multifunctional chimeric terminal proteins to 5' DNA ends: A potential new strategy for assembly of synthetic therapeutic gene vectors.</gtr:title><gtr:parentPublicationTitle>Medical hypotheses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e6b934125a1682dce74076115330a1a"><gtr:id>0e6b934125a1682dce74076115330a1a</gtr:id><gtr:otherNames>Tolmachov O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0306-9877</gtr:issn><gtr:outcomeId>50D080A61C0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CB6B5D8-8EB4-4636-A6FA-B775F8ED70AD</gtr:id><gtr:title>Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector.</gtr:title><gtr:parentPublicationTitle>Gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f34f6595a51e0ebb083644c167a286c"><gtr:id>8f34f6595a51e0ebb083644c167a286c</gtr:id><gtr:otherNames>Argyros O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0969-7128</gtr:issn><gtr:outcomeId>131D81908A6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0104852-23BB-46CF-9E4C-F3B9D5A6591D</gtr:id><gtr:title>Strategies for the episomal modification of cells.</gtr:title><gtr:parentPublicationTitle>Current opinion in molecular therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf3c4e446c514870be86286f3e93b102"><gtr:id>cf3c4e446c514870be86286f3e93b102</gtr:id><gtr:otherNames>Wong SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1464-8431</gtr:issn><gtr:outcomeId>B73D8148446</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06F47EA2-E7B8-419D-93E6-C4F909C69EB5</gtr:id><gtr:title>Delivery and long-term expression of a 135 kb LDLR genomic DNA locus in vivo by hydrodynamic tail vein injection.</gtr:title><gtr:parentPublicationTitle>The journal of gene medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f056c409aede7073750d20c637e7b07f"><gtr:id>f056c409aede7073750d20c637e7b07f</gtr:id><gtr:otherNames>Hibbitt OC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1099-498X</gtr:issn><gtr:outcomeId>95923F2D593</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F42CF83C-20A5-4EBA-A806-645E4CD20CB6</gtr:id><gtr:title>Synthesis and application of integrin targeting lipopeptides in targeted gene delivery.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdb219eada82ebc6f86acb14980d141d"><gtr:id>bdb219eada82ebc6f86acb14980d141d</gtr:id><gtr:otherNames>Waterhouse JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>8EBC8D86231</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0300705</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>